Life Science Business of Merck Breaks Ground on Company’s First Lateral Flow Membrane Production Facility in the United States

Supports strategy to add physical capacity and expand regional network in the United States

22-Jul-2022 - The Life Science business of Merck broke ground at its Sheboygan, Wisconsin site, for the company’s first lateral flow membrane production facility in the United States. Lateral flow membranes are a key component in rapid diagnostic test kits for a variety of applications, including Covid-19 ...

Tears instead of Blood

Sensor with separation capability: diagnosing jaundice using tear fluids

28-Jun-2022 - Human tear fluids contain many proteins, metabolites, and other molecules whose concentrations change significantly with certain diseases. A research team has now developed a handy test kit for tears that can identify patients with jaundice. Their success is based on a hybrid sensor that ...

PerkinElmer Completes Acquisition of Oxford Immunotec

12-Mar-2021 - PerkinElmer, Inc. announced that the Company has completed its previously announced acquisition of Oxford Immunotec Global PLC (Oxford Immunotec). PerkinElmer originally announced its intent to acquire Oxford Immunotec on January 7, 2021. “Oxford Immunotec’s global role in fighting tuberculosis, ...

QIAGEN launches coronavirus test kit in Germany following derogation by BfArM

19-Mar-2020 - QIAGEN announced that it has obtained derogation in Germany by the Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) for its newly developed QIAstat-Dx Respiratory SARS-CoV-2 Panel test to be sold as an in vitro diagnostic (“IVD”) for the detection of SARS-CoV-2. At the same time, the ...

Merck Acquires BioControl to Strengthen Position in Food Safety Testing

05-Jan-2017 - Merck announced it has acquired BioControl Systems Inc., a global leader in food safety testing. The acquisition opens growth opportunities for Merck in the food and beverage space; particularly in the U.S. Confidentiality has been agreed on the financial details of the transaction. BioControl’s ...

Multiplicom receives €200,000 grant for novel non-invasive pre-natal test

IWT grant to support development of early aneuploidy detection during pregnancy

13-Jun-2012 - Multiplicom, a molecular diagnostics company specializing in the design, development, production and commercialization of molecular genetic tests based on massively parallel sequencing, announced that it has been awarded a €200,000 grant from the Flemish agency for Innovation by Science and ...

H5N1 Bird Flu Diagnostic Kit Detects All Known Strains of H5N1 Virus with a Single Test

31-May-2012 - The close collaboration between scientists from the Experimental Therapeutics Centre (ETC) under the Agency for Science and Technology Research (A*STAR) and clinicians from Tan Tock Seng Hospital (TTSH) has enabled the successful development of the most comprehensive and rapid H5N1 bird flu test ...